The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps

David S Alberts, Janine G Einspahr, Cheryl Ritenbaugh, Mikel Aickin, Shirley Rees-McGee, Jan Atwood, Scott Emerson, Nancy Mason-Liddil, Lawrence Bettinger, Jagdish Patel, Sharad Bellapravalu, Paravasthu S. Ramanujam, John Phelps, Larry Clark

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Colorectal cancers continue as the second most common cause of death from cancer in the United States. Only a few prospective, randomized clinical trials have been performed to evaluate the potential preventive effects of dietary fiber or calcium in patients with an increased risk for the development or recurrence of colorectal cancer. We designed and conducted a double-blinded, placebo-controlled randomized trial involving supplementation of fiber and calcium intake and measurements of [3H]thymidine labeling index (LI) percentages in rectal mucosal biopsies obtained from patients with resected colorectal adenomas to examine the potential mechanisms by which dietary interventions might reduce colorectal cancer risk. We performed a randomized, double-blinded, Phase II study, using a factorial design to measure the effects of supplemental dietary wheat bran fiber (2.0 or 13.5 g/day) and calcium carbonate (250 or 1500 mg/day elemental calcium) supplementation on [3H]thymidine LI percentages in rectal mucosal crypts and 24.h in vitro outgrowth cultures. Measurements were made at baseline randomization (ie., after a 3-month placebo run-in period using 2.0 g of wheat bran fiber plus 250 mg of calcium carbonate) and after 3 and 9 months on treatment in 100 randomized participants who had a history of colon adenoma resection. Neither the wheat bran fiber nor the calcium carbonate supplements significantly reduced [3H]thymidine LI percentages in rectal mucosal crypts (total or compartmental analysis) or 24-h in vitro outgrowth cultures at either 3 or 9 months of daily supplementation in the 93 evaluable participants. We conclude that 9 months of high-dose wheat bran fiber and calcium carbonate supplementation in study participants with a history of recently resected colorectal adenomas does not have a significant effect on cellular proliferation rates in rectal mucosal biopsies, comparing 3- and 9- month results to baseline results. Ultimately, there is great need for the evaluation of these two different nutrient interventions in the setting of Phase III studies wherein adenomatous polyp recurrence, rather than a rectal mucosal biomarker, serves as the primary end point.

Original languageEnglish (US)
Pages (from-to)161-169
Number of pages9
JournalCancer Epidemiology Biomarkers and Prevention
Volume6
Issue number3
StatePublished - 1997

Fingerprint

Adenomatous Polyps
Dietary Fiber
Calcium Carbonate
Calcium
Adenoma
Thymidine
Colorectal Neoplasms
Randomized Controlled Trials
Placebos
Biopsy
Recurrence
Dietary Calcium
Random Allocation
Cause of Death
Colon
Biomarkers
Cell Proliferation
Food
Neoplasms

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps. / Alberts, David S; Einspahr, Janine G; Ritenbaugh, Cheryl; Aickin, Mikel; Rees-McGee, Shirley; Atwood, Jan; Emerson, Scott; Mason-Liddil, Nancy; Bettinger, Lawrence; Patel, Jagdish; Bellapravalu, Sharad; Ramanujam, Paravasthu S.; Phelps, John; Clark, Larry.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 6, No. 3, 1997, p. 161-169.

Research output: Contribution to journalArticle

Alberts, DS, Einspahr, JG, Ritenbaugh, C, Aickin, M, Rees-McGee, S, Atwood, J, Emerson, S, Mason-Liddil, N, Bettinger, L, Patel, J, Bellapravalu, S, Ramanujam, PS, Phelps, J & Clark, L 1997, 'The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps', Cancer Epidemiology Biomarkers and Prevention, vol. 6, no. 3, pp. 161-169.
Alberts, David S ; Einspahr, Janine G ; Ritenbaugh, Cheryl ; Aickin, Mikel ; Rees-McGee, Shirley ; Atwood, Jan ; Emerson, Scott ; Mason-Liddil, Nancy ; Bettinger, Lawrence ; Patel, Jagdish ; Bellapravalu, Sharad ; Ramanujam, Paravasthu S. ; Phelps, John ; Clark, Larry. / The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps. In: Cancer Epidemiology Biomarkers and Prevention. 1997 ; Vol. 6, No. 3. pp. 161-169.
@article{df24caba3066450d86c717a899de9118,
title = "The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps",
abstract = "Colorectal cancers continue as the second most common cause of death from cancer in the United States. Only a few prospective, randomized clinical trials have been performed to evaluate the potential preventive effects of dietary fiber or calcium in patients with an increased risk for the development or recurrence of colorectal cancer. We designed and conducted a double-blinded, placebo-controlled randomized trial involving supplementation of fiber and calcium intake and measurements of [3H]thymidine labeling index (LI) percentages in rectal mucosal biopsies obtained from patients with resected colorectal adenomas to examine the potential mechanisms by which dietary interventions might reduce colorectal cancer risk. We performed a randomized, double-blinded, Phase II study, using a factorial design to measure the effects of supplemental dietary wheat bran fiber (2.0 or 13.5 g/day) and calcium carbonate (250 or 1500 mg/day elemental calcium) supplementation on [3H]thymidine LI percentages in rectal mucosal crypts and 24.h in vitro outgrowth cultures. Measurements were made at baseline randomization (ie., after a 3-month placebo run-in period using 2.0 g of wheat bran fiber plus 250 mg of calcium carbonate) and after 3 and 9 months on treatment in 100 randomized participants who had a history of colon adenoma resection. Neither the wheat bran fiber nor the calcium carbonate supplements significantly reduced [3H]thymidine LI percentages in rectal mucosal crypts (total or compartmental analysis) or 24-h in vitro outgrowth cultures at either 3 or 9 months of daily supplementation in the 93 evaluable participants. We conclude that 9 months of high-dose wheat bran fiber and calcium carbonate supplementation in study participants with a history of recently resected colorectal adenomas does not have a significant effect on cellular proliferation rates in rectal mucosal biopsies, comparing 3- and 9- month results to baseline results. Ultimately, there is great need for the evaluation of these two different nutrient interventions in the setting of Phase III studies wherein adenomatous polyp recurrence, rather than a rectal mucosal biomarker, serves as the primary end point.",
author = "Alberts, {David S} and Einspahr, {Janine G} and Cheryl Ritenbaugh and Mikel Aickin and Shirley Rees-McGee and Jan Atwood and Scott Emerson and Nancy Mason-Liddil and Lawrence Bettinger and Jagdish Patel and Sharad Bellapravalu and Ramanujam, {Paravasthu S.} and John Phelps and Larry Clark",
year = "1997",
language = "English (US)",
volume = "6",
pages = "161--169",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps

AU - Alberts, David S

AU - Einspahr, Janine G

AU - Ritenbaugh, Cheryl

AU - Aickin, Mikel

AU - Rees-McGee, Shirley

AU - Atwood, Jan

AU - Emerson, Scott

AU - Mason-Liddil, Nancy

AU - Bettinger, Lawrence

AU - Patel, Jagdish

AU - Bellapravalu, Sharad

AU - Ramanujam, Paravasthu S.

AU - Phelps, John

AU - Clark, Larry

PY - 1997

Y1 - 1997

N2 - Colorectal cancers continue as the second most common cause of death from cancer in the United States. Only a few prospective, randomized clinical trials have been performed to evaluate the potential preventive effects of dietary fiber or calcium in patients with an increased risk for the development or recurrence of colorectal cancer. We designed and conducted a double-blinded, placebo-controlled randomized trial involving supplementation of fiber and calcium intake and measurements of [3H]thymidine labeling index (LI) percentages in rectal mucosal biopsies obtained from patients with resected colorectal adenomas to examine the potential mechanisms by which dietary interventions might reduce colorectal cancer risk. We performed a randomized, double-blinded, Phase II study, using a factorial design to measure the effects of supplemental dietary wheat bran fiber (2.0 or 13.5 g/day) and calcium carbonate (250 or 1500 mg/day elemental calcium) supplementation on [3H]thymidine LI percentages in rectal mucosal crypts and 24.h in vitro outgrowth cultures. Measurements were made at baseline randomization (ie., after a 3-month placebo run-in period using 2.0 g of wheat bran fiber plus 250 mg of calcium carbonate) and after 3 and 9 months on treatment in 100 randomized participants who had a history of colon adenoma resection. Neither the wheat bran fiber nor the calcium carbonate supplements significantly reduced [3H]thymidine LI percentages in rectal mucosal crypts (total or compartmental analysis) or 24-h in vitro outgrowth cultures at either 3 or 9 months of daily supplementation in the 93 evaluable participants. We conclude that 9 months of high-dose wheat bran fiber and calcium carbonate supplementation in study participants with a history of recently resected colorectal adenomas does not have a significant effect on cellular proliferation rates in rectal mucosal biopsies, comparing 3- and 9- month results to baseline results. Ultimately, there is great need for the evaluation of these two different nutrient interventions in the setting of Phase III studies wherein adenomatous polyp recurrence, rather than a rectal mucosal biomarker, serves as the primary end point.

AB - Colorectal cancers continue as the second most common cause of death from cancer in the United States. Only a few prospective, randomized clinical trials have been performed to evaluate the potential preventive effects of dietary fiber or calcium in patients with an increased risk for the development or recurrence of colorectal cancer. We designed and conducted a double-blinded, placebo-controlled randomized trial involving supplementation of fiber and calcium intake and measurements of [3H]thymidine labeling index (LI) percentages in rectal mucosal biopsies obtained from patients with resected colorectal adenomas to examine the potential mechanisms by which dietary interventions might reduce colorectal cancer risk. We performed a randomized, double-blinded, Phase II study, using a factorial design to measure the effects of supplemental dietary wheat bran fiber (2.0 or 13.5 g/day) and calcium carbonate (250 or 1500 mg/day elemental calcium) supplementation on [3H]thymidine LI percentages in rectal mucosal crypts and 24.h in vitro outgrowth cultures. Measurements were made at baseline randomization (ie., after a 3-month placebo run-in period using 2.0 g of wheat bran fiber plus 250 mg of calcium carbonate) and after 3 and 9 months on treatment in 100 randomized participants who had a history of colon adenoma resection. Neither the wheat bran fiber nor the calcium carbonate supplements significantly reduced [3H]thymidine LI percentages in rectal mucosal crypts (total or compartmental analysis) or 24-h in vitro outgrowth cultures at either 3 or 9 months of daily supplementation in the 93 evaluable participants. We conclude that 9 months of high-dose wheat bran fiber and calcium carbonate supplementation in study participants with a history of recently resected colorectal adenomas does not have a significant effect on cellular proliferation rates in rectal mucosal biopsies, comparing 3- and 9- month results to baseline results. Ultimately, there is great need for the evaluation of these two different nutrient interventions in the setting of Phase III studies wherein adenomatous polyp recurrence, rather than a rectal mucosal biomarker, serves as the primary end point.

UR - http://www.scopus.com/inward/record.url?scp=16944365473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16944365473&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 161

EP - 169

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 3

ER -